| ORIGINAL ARTICLE
|Year : 2000 | Volume
| Issue : 2 | Page : 73--75
An open trial of pentoxifylline in schamberg's disease
Leishiowon Kumrah, Renu George, Soshamma George
Fifteen patients with Schamberg's disease were enrolled in the study. Each patient was given 400mg of pentoxifylline once a day for 8 weeks. Skin biopsy was done in 6 patients to document the disease. Pretreatment and post treatment evaluation were made. There was no objective improvement in any of the patients though 4 reported subjective improvement in their pigmentation.
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF Not available]*